Darolutamide (BAY1841788) + docetaxel + ADT: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

3

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Not applicable 1

Conditions being studied

Condition	Trials
Low-volume Metastasis	1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)	1
Prostate cancer	1

Recruiting trials involving Darolutamide (BAY1841788) + docetaxel + ADT

A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer
NCT06661122 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many recruiting trials involve Darolutamide (BAY1841788) + docetaxel + ADT?

1 recruiting trial across 3 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.